酒渣鼻
异维甲酸
红斑
医学
皮肤病科
置信区间
内科学
痤疮
作者
Meltem Uslu,Ekin Şavk,Göksun Karaman,Neslihan Şendur
标识
DOI:10.2340/00015555-1204
摘要
Isotretinoin is one of the therapeutic options for rosacea. However, the response of erythema to treatment with isotretinoin is usually slow and incomplete with common (0.5–1 mg/kg/day) or low (10 mg/day) doses. This study investigated the efficacy of, and relapse on, 20 mg/day isotretinoin treatment in rosacea, with the aid of instrumental measurement of facial erythema and sebum levels. A 20 mg/day dose of isotretinoin was given for 4 months, and then the dose was tapered off within the following 6 months. A total of 25 patients were included in the study. Papule and pustule counts, erythema index, sebum level, dermatologist’s and patient’s erythema scores, and dermatologist’s sebum scores were significantly lower in the first month of therapy compared with pre-treatment values (p < 0.05). Within a median follow-up of 11 months (95% confidence interval: 8.4–13.5 months) 45% of patients had a relapse. In conclusion, 20 mg/day isotretinoin was rapidly efficient for reducing both inflammatory lesions and erythema in rosacea.
科研通智能强力驱动
Strongly Powered by AbleSci AI